Table 10 Hemodynamic parameters at baseline and the end of follow up in the included cohort studies (n = 18)
N | EOA cm2 | Peak Gradient mmHg | Mean Gradient mmHg | ||||
|---|---|---|---|---|---|---|---|
Baseline | End of follow up | Baseline | End of follow up | Baseline | End of follow up | ||
Sadowski 2015 [12] | 20 | 1.0 ± 0.5 | 1.8 ± 0.5 | NA | NA | 54.8 ± 21.2 | 11.3 ± 3.4 |
Bartus 2018 [20] | 133 | 1.0 ± 0.8 | 1.8 ± 0.6 | NA | NA | 49.4 ± 21.7 | 13.9 ± 6.1 |
Bartus 2019 [21] | 1.6 ± 0.4 | 78.5 ± 32.9 | 26.0 ± 12.9 | 14.5 ± 7.4 | |||
Bartus 2021 [22] | 1.4 ± 0.5 | NA | NA | 14.8 ± 7.6 | |||
Puskas 2017 [24] | 689 | NA | 1.6 ± 0.5 | NA | NA | NA | 10.1 ± 4.3 |
Johnston 2021 [25] | NA | 1.5 ± 0.5 | 64.8 ± 27.5 | 21.0 ± 10.4 | 33.0 ± 14.5 | 11.0 ± 5.6 | |
Beaver 2023 [26] | NA | 1.82 ± 0.57 | NA | NA | NA | 9.4 ± 4.5 | |
El-Sayed Ahmad 2021 [18] | 100 | 0.9 ± 0.4 | 1.8 ± 0.1 | 71.3 ± 22.1 | 22.1 ± 3.1 | 42.1 ± 14.0 | 11.5 ± 2.3 |
El-Sayed Ahmad 2022 [23] | 154 | 0.9 ± 0.2 | 1.9 ± 0.4 | 76.5 ± 19.4 | 23.6 ± 7.7 | 46.1 ± 12.3 | 13.9 ± 5.9 |
Bernard 2023 [32] | 217 | NA | NA | NA | NA | 40.5 ± 18.9 | 11.4 ± 3.6 |
Chiariello 2023 [35] | 74 | NA | 1.5 (1.3–1.7) | NA | 21 (16–26) | NA | 12 (10–15) |
Francica 2023 [40] | 122 | NA | NA | 65.8 ± 28.2 | 22.7 ± 9.1 | 43.9 ± 17.1 | 12.6 ± 5.5 |
Fukunaga 2022 [29] | 29 | 0.72 ± 0.26 | 1.67 ± 0.36 | 89.3 ± 34.9 | 22.1 ± 6.7 | 51.9 ± 18.4 | 11.2 ± 3.3 |
Maeda 2023 [34] | 64 | 0.75 ± 0.20 | 1.69 ± 0.34 | NA | NA | 50.2 ± 17.2 | 10.7 ± 5.1 |
Meuris 2023 [28] | 421 | 1.07 ± 0.76 | 1.9 ± 0.6 | 70.6 ± 33.3 | 12.5 ± 5.3 | 45.3 ± 21.5 | 12.6 |
Porto 2023 [41] | 487 | NA | NA | NA | NA | 49 (43–55) | 9 (7–12) |
Shala 2022 [33] | 59 | NA | NA | NA | NA | NA | 10 (11 − 7) |
Useini 2021 [27] | 80 | NA | NA | 78.6 ± 22.8 | 19 ± 7.2 | 46.7 ± 14.8 | 10.2 ± 4.1 |